• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Blocking the 'MIDAS' touch of Enterococcus faecalis

    Thumbnail
    View/Open
    103743_1.pdf (319.9Kb)
    File version
    Version of Record (VoR)
    Author(s)
    Schembri, Mark A
    Lo, Alvin W
    Ulett, Glen C
    Griffith University Author(s)
    Ulett, Glen C.
    Year published
    2015
    Metadata
    Show full item record
    Abstract
    The treatment and prevention of hospital-acquired infections represents a major challenge to patient care. It is estimated that approximately 1.7 million hospital-acquired infections occur annually in the United States alone, accounting for almost 100,000 deaths and $5-10 billion in associated health care costs (1,2). Catheter-associated urinary tract infections (CAUTI) account for up to 40% of all hospital-acquired infections (3), and thus constitute the greatest burden of acquired disease in the nosocomial environment. The risk of bacteriuria in catheterized patients is estimated to be 5-10% per day (4), and most patients ...
    View more >
    The treatment and prevention of hospital-acquired infections represents a major challenge to patient care. It is estimated that approximately 1.7 million hospital-acquired infections occur annually in the United States alone, accounting for almost 100,000 deaths and $5-10 billion in associated health care costs (1,2). Catheter-associated urinary tract infections (CAUTI) account for up to 40% of all hospital-acquired infections (3), and thus constitute the greatest burden of acquired disease in the nosocomial environment. The risk of bacteriuria in catheterized patients is estimated to be 5-10% per day (4), and most patients with an indwelling urinary catheter for 30 days or longer develop bacteriuria (5). Multidrug resistance (MDR) is now frequently associated with pathogens that cause CAUTI, leading to increased rates of treatment failure with standard antibiotic therapies and a rise in the use of second and third-line agents. A wide-range of Gram-positive and Gram-negative organisms can cause CAUTI, including Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus spp. and Enterococcus spp. (6). Enterococcus spp., in particular Enterococcus faecalis (E. faecalis), cause up to 25% of all CAUTIs and are increasingly associated with MDR in the nosocomial setting (7-9). Here we review the exciting new findings reported by Flores-Mireles and co-workers, who have defined the mechanism of growth and biofilm formation by E. faecalis in human urine, and translated this new knowledge into the development of a vaccine that can prevent CAUTI in a mouse infection model (10).
    View less >
    Journal Title
    Annals of Translational Medicine
    Volume
    3
    Issue
    Suppl. 1
    DOI
    https://doi.org/10.3978/j.issn.2305-5839.2015.03.32
    Copyright Statement
    © 2015 AME Publishing Company. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
    Subject
    Medical bacteriology
    Publication URI
    http://hdl.handle.net/10072/155789
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander